Immunogenics (United States)

Recent papers from Immunogenics (United States)

1. An uphill path to commercialization of silver nanoparticle antimicrobials: from bench to marketNanomedicine · 2025
2. Dynamics of Serologic Change to Gluten in Celiac Disease PatientsNutrients · 2023
3. A Composite Morphometric Duodenal Biopsy Mucosal Scale for Celiac Disease Encompassing Both Morphology and InflammationClinical Gastroenterology and Hepatology · 2023
4. Proteomic Profiling of Extracellular Matrix Components from Patient Metastases Identifies Consistently Elevated Proteins for Developing Nanobodies That Target Primary Tumors and MetastasesCancer Research · 2023
5. Silver nanoparticles enhance the efficacy of aminoglycosides against antibiotic-resistant bacteriaFrontiers in Microbiology · 2023
6. Evaluation of bactericidal effects of silver hydrosol nanotherapeutics against Enterococcus faecium 1449 drug resistant biofilmsFrontiers in Cellular and Infection Microbiology · 2023
7. Characterization of the Silver Nanoparticles in the Sovereign Silver® and Argentyn 23®, Bio-Active Silver Hydrosol™ Products [Letter]International Journal of Nanomedicine · 2022
8. A Statistical and Dynamical Model for Forecasting COVID-19 Deaths based on a Hybrid Asymmetric Gaussian and SEIR Construct2020
9. Latiglutenase treatment for celiac disease: symptom and quality of life improvement for seropositive patients on a gluten‐free dietGastroHep · 2019
10. Evaluation of Qualitative and Quantitative Immunoassays To Detect Barley Contamination in Gluten-Free Beer with Confirmation Using LC/MS/MSJournal of AOAC International · 2014